IBG Beteiligungsgesellschaft Sachsen-Anhalt

Wingfield GmbH, founded in 2017 and based in Hanover, Germany, specializes in developing a software system that transforms any tennis court into a smart court. This innovative system integrates hardware and artificial intelligence to track scores, analyze strokes, and provide personalized feedback immediately after matches or practice sessions. Wingfield's technology offers amateur players access to advanced game analytics typically reserved for professionals, all at a fraction of the cost of traditional systems. Additionally, the user-friendly setup enables coaches to effectively plan and review their players' training progress, enhancing the overall tennis experience for both players and coaches alike.

Baby Sweets GmbH & Co. KG is an online retailer based in Leuna, Germany, specializing in baby clothing and accessories for boys and girls. The company offers a diverse range of products, including rompers, bodysuits, pajamas, dresses, and jackets, alongside essential baby accessories such as feeding items, bathing supplies, and play items. Designed to cater to the needs of parents and gift-givers, Baby Sweets features both its own brands manufactured in the EU and selected international brands. The company's focus is on providing cute, high-quality, and unique products that support parents during the early years of their child's life.

COMAN Software provides innovative software for project management in machine and plant construction.

Lab-on-Fiber GmbH engages in the development, commercialization, and production of fiber delivery and laser systems. It offers surgical fiber probes and urology fiber probes. Lab-on-Fiber GmbH is based in Halle, Germany.

Urwahn Engineering is a developer of innovative bicycles aimed at enhancing urban mobility. The company focuses on creating bicycles that combine a purist design with practical features suitable for daily use. Their products are equipped with integrated LED lighting and GPS tracking systems, catering specifically to the needs of urban commuters. By offering smart and sustainable mobility solutions, Urwahn Engineering seeks to revolutionize the cycling experience in urban environments.

DCI Digital Car Institute GmbH, based in Halle, Germany, specializes in developing advanced scan sensor software and solutions for the digital assessment of vehicle valuations and inspection reports. The company is recognized for its automated digitization technology that creates comprehensive 3D models of vehicles, facilitating accurate damage assessment and vehicle valuation. These models also support peer-to-peer marketing and innovative re-marketing strategies for automobiles. DCI caters to various clients, including vehicle fleet managers, leasing companies, insurance providers, and used car dealers, thereby enhancing their operations through efficient digital solutions. The institute focuses on integrating artificial intelligence into its products to pioneer new business models within the automotive sector.

TESVOLT GmbH, founded in 2014 and based in Wittenberg, Germany, specializes in the manufacturing of innovative lithium battery storage systems tailored for the commercial and industrial sectors. The company focuses on developing flexible battery storage solutions with high capacities, aiming to enhance the use of renewable energy sources such as solar, wind, and biogas. With a commitment to quality "Made in Germany," TESVOLT assembles its energy storage systems domestically and collaborates with strategic partners to advance its technology. Co-founders Daniel Hannemann and Simon Schandert bring extensive experience from the photovoltaic sector, driving the company’s ambition to deliver economical and efficient energy storage solutions. Their systems are designed with an active battery management system, ensuring optimal performance in charging and discharging, thereby enhancing durability and reliability for businesses looking to harness renewable energy effectively.

Arzneimittelwerk Warngau is a pharmaceutical company based in Warngau, Germany, specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2008 by Wilfried Fischer, the company focuses on creating therapeutic solutions primarily in the fields of oncology, pain therapy, and neurology. Its product portfolio includes active ingredient and biodegradable implants, as well as transdermal systems, featuring both passive and microchip-controlled patches. Through its commitment to advancing drug delivery technologies, Arzneimittelwerk Warngau aims to improve patient outcomes in various therapeutic areas.

2tainment GmbH is a PC and video games publisher with its own development resources. The company concentrates on developing and marketing hardware and software entertainment products internationally. 2tainment is extremely focused on line-up development and marketing. A selected portfolio ensures individual products receive the best-possible attention in the long term. This benefits players, developers, distributors and retailers alike. The company's own development team emphasises implementing own content for virtual and augmented reality, and supporting external development studios whose games are marketed by 2tainment. The team also works beyond the industry, in research and development, realising medical projects among others. Its own VR & AR expertise helps improve conventional treatment methods. With its own line of hardware products, 2tainment focuses on high-quality PC, mobile and video game accessories. Bundling them with matching software creates additional synergies.

Arzneimittelwerk Warngau is a pharmaceutical company based in Warngau, Germany, specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2008 by Wilfried Fischer, the company focuses on creating therapeutic solutions primarily in the fields of oncology, pain therapy, and neurology. Its product portfolio includes active ingredient and biodegradable implants, as well as transdermal systems, featuring both passive and microchip-controlled patches. Through its commitment to advancing drug delivery technologies, Arzneimittelwerk Warngau aims to improve patient outcomes in various therapeutic areas.

Micropelt is a startup that emerged from a collaborative project between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Germany. The company specializes in developing thin film thermoelectric components through semiconductor manufacturing processes. Micropelt focuses on creating energy-harvesting systems that integrate micro-actuators and sensors. Its product offerings include thermoelectric cooling chips and thermoelectric generators designed for various applications, such as chip spot cooling, biomedical devices, heating, ventilation, and air conditioning systems, as well as fiber optics. These innovations aim to facilitate effective temperature management in individual rooms while contributing to CO2 reduction and enhancing user comfort. The company has secured funding from several financial institutions, enabling its growth and development within the thin-film technology sector.

Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.

TME Pharma is a biotechnology company based in Berlin, Germany, focused on developing innovative therapeutics for cancer treatment. The company utilizes its proprietary Spiegelmer platform, which involves biostable aptamers and mirror image nucleic acids, to create a pipeline of clinical-stage product candidates. Its lead drug candidate, NOX-A12, is being investigated as a combination therapy for various cancer types, including metastatic pancreatic and colorectal cancer, glioblastoma, myeloma, and chronic lymphocytic leukemia. TME Pharma is also advancing NOX-E36, which has completed Phase IIa trials for diabetic nephropathy. The company has established partnerships, including a collaboration with Merck & Co. to explore the efficacy of NOX-A12 in combination with Keytruda in patients with metastatic solid tumors. Founded in 1997, TME Pharma continues to advance its mission of developing novel treatments for serious medical conditions.

Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.

KeyNeurotek is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases.

EUCODIS Bioscience GmbH is an enzyme engineering company specializing in the manufacture of high-performance enzyme solutions for various industries, including biopharma, fine chemicals, and cosmetics. Founded in 2007 and based in Vienna, Austria, with a subsidiary in Germany, the company offers a diverse range of enzymes such as lipases, peroxidases, phospholipase D, and nitril hydratases, among others. EUCODIS Bioscience also provides services in protein and enzyme engineering, bioprocess development, final formulation, analysis, and industrial manufacturing. Its products are utilized in applications such as the biocatalytic resolution of chiral compounds for pharmaceutical synthesis, the production of sensitive esters, and the synthesis of emollient esters for cosmetic formulations. The company serves a clientele of leading firms across the chemical, pharmaceutical, food, feed, and cosmetics sectors.

20/10 Perfect Vision has develops, manufactures and markets innovative technologies for raising refractive surgery well beyond current expectations. The company's FEMTEC femtosecond laser workstation is set to revolutionize the ophthalmic surgery market, while keeping ease-of-use and patient safety as primary objectives.

TME Pharma is a biotechnology company based in Berlin, Germany, focused on developing innovative therapeutics for cancer treatment. The company utilizes its proprietary Spiegelmer platform, which involves biostable aptamers and mirror image nucleic acids, to create a pipeline of clinical-stage product candidates. Its lead drug candidate, NOX-A12, is being investigated as a combination therapy for various cancer types, including metastatic pancreatic and colorectal cancer, glioblastoma, myeloma, and chronic lymphocytic leukemia. TME Pharma is also advancing NOX-E36, which has completed Phase IIa trials for diabetic nephropathy. The company has established partnerships, including a collaboration with Merck & Co. to explore the efficacy of NOX-A12 in combination with Keytruda in patients with metastatic solid tumors. Founded in 1997, TME Pharma continues to advance its mission of developing novel treatments for serious medical conditions.

metraTec develops, manufactures and sells RF hardware for the product segments 'Identification' (RFID), 'Indoor Localization', 'Wireless Mesh Communication' and 'Wireless Power'. The company serves a variety of industries (mainly logistics, healthcare and security), both with standard products as well as custom solutions. Its customers are mainly system integrators, OEM customers and research institutes worldwide with a focus on Europe.

Curacyte GmbH is a biopharmaceutical company based in Munich, Germany, founded in 2001. The company specializes in developing therapeutics for acute and critical care, focusing on advanced biopharmaceutics aimed at treating conditions in hematology, antithrombosis, and oncology. By creating innovative medicines, Curacyte seeks to provide new generation treatments that address the needs of patients facing severe health challenges.

CSG Solar is one of the leading players in thin-film solar technology. The company gets its name (Crystalline Silicon on Glass) from its technology, in which an extremely thin layer of silicon is deposited directly onto a glass sheet. This captures the already proven qualities of silicon in solar cells while significantly reducing the total amount of silicon required.